Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0264 Transporter Info
Gene Name SLC2A6
Transporter Name Glucose transporter type 6
Gene ID
11182
UniProt ID
Q9UGQ3
Epigenetic Regulations of This DT (EGR)

microRNA

  Unclear Phenotype

          17 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 miR-1227 directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-1227 miRNA Mature ID miR-1227-3p

miRNA Sequence

 CGUGCCACCCUUUUCCCCAG

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 2

 miR-129 directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-129 miRNA Mature ID miR-129-5p

miRNA Sequence

 CUUUUUGCGGUCUGGGCUUGC

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 3

 miR-208a directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-208a miRNA Mature ID miR-208a-5p

miRNA Sequence

 GAGCUUUUGGCCCGGGUUAUAC

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 4

 miR-208b directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-208b miRNA Mature ID miR-208b-5p

miRNA Sequence

 AAGCUUUUUGCUCGAAUUAUGU

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 5

 miR-26b directly targets SLC2A6 [ 2 ]

Epigenetic Type

 microRNA Experiment Method Microarray

miRNA Stemloop ID

 miR-26b miRNA Mature ID miR-26b-5p

miRNA Sequence

 UUCAAGUAAUUCAGGAUAGGU

miRNA Target Type

 Direct

Experimental Material

 Human cervical cancer cell line (Hela)

  Epigenetic Phenomenon 6

 miR-3149 directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-3149 miRNA Mature ID miR-3149

miRNA Sequence

 UUUGUAUGGAUAUGUGUGUGUAU

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 7

 miR-3665 directly targets SLC2A6 [ 3 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-3665 miRNA Mature ID miR-3665

miRNA Sequence

 AGCAGGUGCGGGGCGGCG

miRNA Target Type

 Direct

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 8

 miR-3674 directly targets SLC2A6 [ 3 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-3674 miRNA Mature ID miR-3674

miRNA Sequence

 AUUGUAGAACCUAAGAUUGGCC

miRNA Target Type

 Direct

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 9

 miR-4464 directly targets SLC2A6 [ 3 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-4464 miRNA Mature ID miR-4464

miRNA Sequence

 AAGGUUUGGAUAGAUGCAAUA

miRNA Target Type

 Direct

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 10

 miR-4701 directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-4701 miRNA Mature ID miR-4701-5p

miRNA Sequence

 UUGGCCACCACACCUACCCCUU

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 11

 miR-4715 directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-4715 miRNA Mature ID miR-4715-3p

miRNA Sequence

 GUGCCACCUUAACUGCAGCCAAU

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 12

 miR-4748 directly targets SLC2A6 [ 3 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-4748 miRNA Mature ID miR-4748

miRNA Sequence

 GAGGUUUGGGGAGGAUUUGCU

miRNA Target Type

 Direct

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 13

 miR-500b directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-500b miRNA Mature ID miR-500b-3p

miRNA Sequence

 GCACCCAGGCAAGGAUUCUG

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 14

 miR-5087 directly targets SLC2A6 [ 3 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-5087 miRNA Mature ID miR-5087

miRNA Sequence

 GGGUUUGUAGCUUUGCUGGCAUG

miRNA Target Type

 Direct

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 15

 miR-657 directly targets SLC2A6 [ 3 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-657 miRNA Mature ID miR-657

miRNA Sequence

 GGCAGGUUCUCACCCUCUCUAGG

miRNA Target Type

 Direct

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 16

 miR-6867 directly targets SLC2A6 [ 1 ]

Epigenetic Type

 microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

 miR-6867 miRNA Mature ID miR-6867-5p

miRNA Sequence

 UGUGUGUGUAGAGGAAGAAGGGA

miRNA Target Type

 Direct

Experimental Material

 Multiple cell lines of human

  Epigenetic Phenomenon 17

 miR-92a directly targets SLC2A6 [ 4 ]

Epigenetic Type

 microRNA Experiment Method CLASH

miRNA Stemloop ID

 miR-92a miRNA Mature ID miR-92a-3p

miRNA Sequence

 UAUUGCACUUGUCCCGGCCUGU

miRNA Target Type

 Direct

Experimental Material

 Human embryonic kidney 293 cells (HEK293)

Methylation
References
1 Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 2013 Jul 15;27(14):1624-32.
2 MicroRNA target prediction by expression analysis of host genes. Genome Res. 2009 Mar;19(3):481-90.
3 Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer. Mol Cell. 2017 Aug 3;67(3):400-410.e7.
4 Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013 Apr 25;153(3):654-65.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.